Publications by authors named "Francois Brunelle"
Article Synopsis
- A study investigated the safety and effectiveness of only 6 months of dual-antiplatelet treatment (DAPT) following the implantation of a BioMatrix biodegradable-polymer coated biolimus-eluting stent (BP-BES) after percutaneous coronary intervention (PCI).
- The research included 2,038 patients in France, who were monitored for 6 and 24 months, focusing on major adverse cardiac and cerebrovascular events (MACCE) as the primary outcome.
- Results showed low rates of MACCE, stent thrombosis, and major bleeding at both 6 and 24 months, suggesting that a shorter DAPT duration is both safe and effective for patients with the BP-BES stent.
Objectives: The French Ebiomatrix registry aimed to confirm the results of the Leaders trial in an all-comer population in France.
Background: The Leaders trial showed the Biolimus-eluting-sent (BES) to be equivalent to the Cypher stent in terms of safety and efficacy at 1 year and superior regarding stent thrombosis after 1 year.
Methods: BES recipients were enrolled in 42 French centers with up to 24-month clinical follow up.